Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma exosomal HERV-K transcripts are increased in amyotrophic lateral sclerosis.

BMC neuroscienceĀ·2026
Same author

At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial.

Muscle & nerveĀ·2026
Same author

The Motor Neuron Disease Register for England, Wales, and Northern Ireland: Protocol for a Population Register.

JMIR research protocolsĀ·2026
Same author

Evaluation of Digital Technologies for Home-Based Assessment in People With Amyotrophic Lateral Sclerosis.

Annals of clinical and translational neurologyĀ·2026
Same author

CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.

Brain : a journal of neurologyĀ·2026
Same author

Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.

Frontiers in neuroscienceĀ·2026

Related Experiment Video

Updated: Apr 23, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.7K

Quantifying disease progression in amyotrophic lateral sclerosis.

Neil G Simon1, Martin R Turner, Steve Vucic

  • 1Department of Neurology, University of California, San Francisco, San Francisco, CA; Prince of Wales Clinical School, University of New South Wales, Randwick, Australia; Neuroscience Research Australia, Barker St, Randwick, Australia.

Annals of Neurology
|September 17, 2014
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) shows varied progression, making objective measurement challenging. This review covers genetic and phenotypic factors, and biomarkers to improve tracking and clinical trials for new treatments.

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.3K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.7K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.3K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Area of Science:

  • Neurology
  • Genetics
  • Biomarkers

Background:

  • Amyotrophic lateral sclerosis (ALS) presents significant heterogeneity in disease onset and progression.
  • Clinical quantitation of ALS progression is difficult due to its complex nature.
  • Understanding ALS pathogenesis necessitates better methods for measuring disease progression.

Purpose of the Study:

  • To review phenotypic and genetic factors influencing ALS progression.
  • To examine current and emerging biomarkers for objective ALS measurement.
  • To discuss implications for clinical trial design and therapeutic development.

Main Methods:

  • Literature review of phenotypic and genetic determinants of ALS progression.
  • Analysis of established and novel biomarkers for ALS.
  • Discussion of strategies for improving clinical trial efficiency.

Main Results:

  • Phenotypic and genetic factors significantly impact ALS progression variability.
  • Biomarkers show promise for objective and robust measurement of disease progression.
  • Improved measurement strategies are crucial for evaluating new ALS therapies.

Conclusions:

  • Objective measurement of ALS progression is critical for advancing treatment.
  • Integrating genetic, phenotypic, and biomarker data can enhance understanding and management of ALS.
  • Optimized clinical trial designs are needed to accelerate the delivery of neuroprotective therapies for ALS.